Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate.

Bioprostheses fabricated from porcine aortic valves are widely used to replace diseased heart valves. Calcification is the principal cause of the clinical failure of these devices. In the present study, inhibition of the calcification of bioprosthetic heart valve cusps implanted subcutaneously in rats was achieved through the adjacent implantation of controlled-release matrices containing the anticalcification agent ethanehydroxydiphosphonate dispersed in a copolymer of ethylene-vinyl acetate. Prevention of calcification was virtually complete, without the adverse effects of retarded bone and somatic growth that accompany systemic administration of ethanehydroxydiphosphonate.

[1]  L Robert,et al.  Biological factors affecting long-term results of valvular heterografts. , 1969, The Journal of thoracic and cardiovascular surgery.

[2]  R. Langer,et al.  Zero-order controlled-release polymer matrices for micro- and macromolecules. , 1983, Journal of pharmaceutical sciences.

[3]  D. Morgan,et al.  The influence of two diphosphonates on calcium metabolism in the rat. , 1972, Clinical science.

[4]  F J Schoen,et al.  Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. , 1983, The American journal of pathology.

[5]  L. Cohn,et al.  Five to eight-year follow-up of patients undergoing porcine heart-valve replacement. , 1981, The New England journal of medicine.

[6]  R. Levy,et al.  Use of Hancock porcine xenografts in children and adolescents. , 1980, The American journal of cardiology.

[7]  G. Rosenberg,et al.  Calcification inside artificial hearts: inhibition by warfarin-sodium. , 1980, Science.

[8]  R. Levy,et al.  Mechanism of calcification of porcine bioprosthetic aortic valve cusps: role of T-lymphocytes. , 1983, The American journal of cardiology.

[9]  R. Levy,et al.  Porcine bioprosthetic valve calcification in bovine left ventricle-aorta shunts: studies of the deposition of vitamin K-dependent proteins. , 1983, The Annals of thoracic surgery.

[10]  W. Roberts,et al.  Structural changes in porcine xenografts used as substitute cardiac valves. Gross and histologic observations in 51 glutaraldehyde-preserved Hancock valves in 41 patients. , 1977, The American journal of cardiology.

[11]  E. Arbustini,et al.  Modification by the Hancock T6 process of calcification of bioprosthetic cardiac valves implanted in sheep. , 1984, The American journal of cardiology.

[12]  P. S. Chen,et al.  Microdetermination of Phosphorus , 1956 .

[13]  A. Carpentier,et al.  Calcifications of cardiac valve bioprostheses. Biochemical, histologic, and ultrastructural observations in a subcutaneous implantation model system. , 1982, The Journal of thoracic and cardiovascular surgery.

[14]  J. Kosek,et al.  Twelve-year experience with glutaraldehyde-preserved porcine xenografts. , 1982, The Journal of thoracic and cardiovascular surgery.

[15]  H. Fleisch,et al.  Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats , 1973, Calcified Tissue Research.